PRESS RELEASE
28 April 2025

IndusLaw Deal Report | Proklean - Greenstone

I
IndusLaw

Contributor

INDUSLAW is a multi-speciality Indian law firm, advising a wide range of international and domestic clients from Fortune 500 companies to start-ups, and government and regulatory bodies.
Our firm advised Proklean Technologies Private Limited and its promoters in relation to the acquisition of 17.99% shares of Proklean by Greenstone Fund Scheme I.
India

Our firm advised Proklean Technologies Private Limited and its promoters in relation to the acquisition of 17.99% shares of Proklean by Greenstone Fund Scheme I.

This transaction involved a secondary sale of shares from existing shareholders and promoters to Greenstone. Proklean is a leading chemical manufacturing company engaged in the business of developing, manufacturing and selling non-toxic and biodegradable formulations based on probiotic technology. [1]

INDUSLAW Team:

Revathy Murali (Partner), Anurag Prasad (Senior Associate), Aryan Mohindroo (Associate) and Ayushi Suman (Associate).

Other law firms involved:

  • Samvad Partners

Contributor

INDUSLAW is a multi-speciality Indian law firm, advising a wide range of international and domestic clients from Fortune 500 companies to start-ups, and government and regulatory bodies.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More